Stromedix inc
WebApr 6, 2009 · May 20, 2011 updated by: Stromedix, Inc. Randomized Double-Blind, Placebo-Controlled, Single and Multiple Dose, Dose-Escalation Study of STX 100 in Renal Transplant Patients With Biopsy Proven Interstitial Fibrosis and Tubular Atrophy (IF/TA) WebCompany Description: Industry: Pharmaceutical and Medicine Manufacturing , Chemical Manufacturing , Manufacturing , Pharmaceutical preparations. See other industries within …
Stromedix inc
Did you know?
WebFeb 14, 2012 · Stromedix is a privately held biotechnology company based in Cambridge, Massachusetts, focused on innovative therapies for fibrosis and organ failure. … WebAug 31, 2010 · Stromedix is a privately held biotechnology company based in Cambridge, Massachusetts, focused on innovative therapies for fibrotic organ failure. Investors in …
WebJul 1, 2012 · Overnight, Cambridge, Mass.-based Stromedix became the next poster child for the virtual biotech model, life science businesses built around a core group of founding executives. WebFeb 14, 2012 · Biogen Idec Inc. said Tuesday it will pay $75 million upfront and as much as $487.5 million in future payments to acquire closely held biotechnology company Stromedix Inc., which is working on a ...
WebSep 17, 2024 · The drug was originally developed by Stromedix, a biotech founded and ran by a former Biogen executive, Michael Gilman. Biogen paid $75 million upfront to acquire … WebJun 3, 2011 · This study was previously posted by Stromedix, Inc. In April, 2014, sponsorship of the trial was transferred to Biogen. The study drug name was changed from STX-100 to BG00011 and the study number was changed from STX-003 to 203PF201, to align with sponsor conventions.
WebFeb 16, 2012 · Biogen Idec has agreed to acquire five-year-old, privately-held Stromedix Inc for $75 million upfront and up to $487.5 million in milestones. But there is a twist to the buyout, as the research programme at the heart of the startup – which is also behind a candidate for idiopathic pulmonary fibrosis (IPF) - began at Biogen.
WebBiogen, Inc. 225 Binney Street, Cambridge, Massachusetts 02142 United States, (617) 679-2000 www.biogen.com Profile M&A Activity (8) M&A Connections (5) M&A Advisors (2) Analytics M&A Summary Buy vs Sell +6 Most Recent M&A M&A by Sector By Geo Top M&A Advisors Deal Values M&A Connections Company Summary SECTOR Life Science … 99影城WebFeb 14, 2012 · Stromedix is a privately held biotechnology company based in Cambridge, Massachusetts, focused on innovative therapies for fibrosis and organ failure. … 99慈善日WebStromedix [Recruiting] Cambridge, Massachusetts, United States, 02141: IPDSharing. Plan to Share IPD: References. Citations: Links: Available IPD/Information: Scroll up to access the controls Scroll to the Study top. U.S. National Library of Medicine ... 99快捷键WebFeb 17, 2012 · Biogen Idec ( BIIB ) recently signed a deal to acquire privately-held biotech company, Stromedix, Inc. With this acquisition, Biogen will gain access. 99征服WebSTROMEDIX, INC. is a Delaware Corporation filed on June 8, 2006. The company's File Number is listed as 4172146. The Registered Agent on file for this company is … 99心率WebCMO Stromedix Inc. (Private Biotech Company developing novel anti-fibrotic therapeutics) Goals: COO/CEO position for early stage biotech company development novel therapeutics for unmet medical needs 99快钱8.6折WebBrand New. Approach to Medicine. A worry-free process customized just for you. Combining Pain Management and Regenerative Medicine. For Orthopedic, Neurodegenerative, … 99快贷